Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase
adverse drug effect
anti-EGFR drugs
pharmacovigilance
renal toxicity
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
24 Nov 2021
24 Nov 2021
Historique:
received:
21
09
2021
revised:
12
11
2021
accepted:
19
11
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
11
12
2021
Statut:
epublish
Résumé
Kidney EGFR expression together with reported cases of glomerular diseases in the context of anti-EGFR drug administration raise concerns about the renal safety profile of these drugs. This issue is addressed in a case/non-case study carried out on VigiBase
Identifiants
pubmed: 34885014
pii: cancers13235907
doi: 10.3390/cancers13235907
pmc: PMC8657199
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Oncol. 2009;2009:567486
pubmed: 19424511
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Drug Resist Updat. 2008 Feb-Apr;11(1-2):32-50
pubmed: 18166498
Mediators Inflamm. 2018 Dec 23;2018:8739473
pubmed: 30670929
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Oncogene. 2002 Mar 27;21(13):2000-8
pubmed: 11960372
Kidney Int. 1996 Mar;49(3):656-65
pubmed: 8648906
J Nephrol. 2017 Apr;30(2):171-180
pubmed: 27154025
Hypertension. 2016 Jul;68(1):17-23
pubmed: 27185750
Nephrol Dial Transplant. 2012 Apr;27(4):1297-304
pubmed: 22467748
Oncologist. 2009 Mar;14(3):284-90
pubmed: 19282350
N Engl J Med. 2005 Jul 14;353(2):123-32
pubmed: 16014882
Nephrol Ther. 2020 Feb;16(1):1-8
pubmed: 31818703
Bull Cancer. 2016 Jan;103(1):18-29
pubmed: 26582734
Kidney Int Rep. 2016 Sep 21;2(1):108-123
pubmed: 29318210
Physiol Rep. 2020 Jul;8(13):e14490
pubmed: 32652816
Cell Mol Life Sci. 2008 May;65(10):1566-84
pubmed: 18259690
N Engl J Med. 2007 Nov 15;357(20):2040-8
pubmed: 18003960
Nat Rev Drug Discov. 2005 Dec;4(12):988-1004
pubmed: 16341064
Trends Pharmacol Sci. 2019 Dec;40(12):941-955
pubmed: 31706618
Transpl Immunol. 2004 Nov;13(3):229-32
pubmed: 15381206
Nat Biotechnol. 2011 Oct 30;29(11):1046-51
pubmed: 22037378
Eur J Cancer. 2006 Nov;42(16):2668-70
pubmed: 16963263
Mol Cancer. 2018 Feb 19;17(1):29
pubmed: 29455654
Science. 1999 Nov 12;286(5443):1358-62
pubmed: 10558990
Lancet. 2005 Oct 29-Nov 4;366(9496):1527-37
pubmed: 16257339
Breast Cancer Res Treat. 2019 May;175(1):5-15
pubmed: 30671765
Gut. 1996 Aug;39(2):262-6
pubmed: 8977341
Expert Opin Drug Saf. 2017 Jul;16(7):761-767
pubmed: 28447485
Curr Oncol Rep. 2012 Aug;14(4):285-94
pubmed: 22544560
Clin Cancer Res. 2006 Sep 15;12(18):5268-72
pubmed: 17000658
Therapie. 2018 May - Jun;73(3):247-255
pubmed: 29174397
Cancer Treat Rev. 2015 Jul;41(7):646-52
pubmed: 26073491
J Thorac Oncol. 2017 Apr;12(4):633-643
pubmed: 28007626
Nephrol Dial Transplant. 2017 Jul 1;32(7):1089-1097
pubmed: 28339780